Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Generic Brinzolamide vs Azopt in Glaucoma/Ocular Hypertension
NCT05022004Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of brinzolamide in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Sun Pharma. Started Dec 2021; status: completed.
02
Drugs
brinzolamide
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT05022004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022004.